Stevenage Bioscience Catalyst (SBC) has announced that Dr Sally Ann Forsyth is to join as CEO in March 2018. Sally, who has been CEO of Norwich Research Park since 2013. Prior to this, she was the first Director for Harwell Oxford, where she was responsible for the establishment of the Harwell Enterprise Zone, inward investment by De Beers and the European Space Agency complemented by the establishment of the UK Space Satellite Catapult Centre. She was also Director of Colworth Science Park, a leading location for open innovation. Sally began her career with Unilever where she held a range of roles across venture capital, technology licensing and alliance management. She holds a PhD in molecular biology from Cambridge University and is a qualified Chartered Global Management Accountant.
